PeptideKey News
Beijing biotech Syneron Bio closes $150M Series B for AI-designed macrocyclic peptides. $250M raised in 5 months, backed by Abu Dhabi sovereign wealth fund.
This article is part of PeptideKey's evidence-based peptide research library covering 100+ compounds with lab-verified purity data.